Professional Documents
Culture Documents
S R Ramesh
Former Professor
Department of Studies in Zoology
University of Mysore, Mysuru, Karnataka
Immunology
Copyright © 2017 by McGraw Hill Education (India) Private Limited. No part of this publication may be reproduced or
distributed in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise or stored in a database
or retrieval system without the prior written permission of the author. The program listings (if any) may be entered, stored and
executed in a computer system, but they may not be reproduced for publication.
Print Edition
ISBN-13: 978-93-5134-322-6
ISBN-10: 93-5134-322-7
EBook Edition
ISBN-13: 978-93-5134-323-3
ISBN-10: 93-5134-323-5
Information contained in this work has been obtained by the McGraw Hill Education (India), from sources believed to
be reliable. However, neither author nor McGraw Hill Education (India) guarantee the accuracy or completeness of any
information published herein, and neither McGraw Hill Education (India) nor its authors shall be responsible for any errors,
omissions, or damages arising out of use of this information. This work is published with the understanding that McGraw Hill
Education (India) and its authors are supplying information but are not attempting to render engineering or other professional
services. If such services are required, the assistance of an appropriate professional should be sought.
Typeset at The Composers, 260, C.A. Apartment, Paschim Vihar, New Delhi 110 063 and printed at
My Alma Mater
University of Mysore
on the occasion of its Centenary Year
&
My Family
for their support and encouragement
&
Faculty and Young Students
who wish to become familiar with immunology
CONTENTS
1.1 Introduction 9
1.2 Types of Immunity 10
1.3 Innate Immunity 11
1.4 Specific Acquired Immunity (Adaptive Immunity) 21
1.5 Interaction Between Innate and Adaptive Immunity 25
Summary 27
Short Answer Questions 28
Essay Type Questions 29
2.1 Introduction 30
2.2 Lymphatic System 30
2.3 Primary Lymphoid Organs 32
2.4 Secondary Lymphoid Organs 34
2.5 Germinal Centres 38
2.6 Tertiary Lymphoid Organs 39
Summary 40
Short Answer Questions 41
Essay Type Questions 41
3.1 Introduction 42
3.2 Hematopoiesis 43
3.3 Phagocytes 45
3.4 Life History of Macrophages 46
3.5 Functions of Monocytes and Macrophages 47
3.6 Lymphocytes 49
viii Contents
4.1 Introduction 63
4.2 Classification of Antigens 68
4.3 Haptens 68
4.4 Superantigens 69
Summary 70
Short Answer Questions 70
Essay Type Questions 71
5.1 Introduction 72
5.2 Structure of Immunoglobulins 73
5.3 Antigen-Antibody Interactions 81
5.4 Antibody Dependent Cell Mediated Cytotoxicity 82
Summary 84
Short Answer Questions 85
Essay Type Questions 85
6.1 Introduction 86
6.2 Development of B Cells 89
6.3 Genetic Basis of Immunoglobulin Diversity 93
6.4 Clonal Selection and Cellular Production of Antibodies 105
Summary 108
Short Answer Questions 109
Essay Type Questions 109
Summary 216
Short Answer Questions 216
Essay Type Questions 216
I was delighted when Dr Ramesh asked me to write the foreword to his book. Dr Ramesh and I were
postgraduate students in the late 70s in Manasagangotri Campus, University of Mysore, Mysuru, Karnataka
which is a wonderful setting for higher learning. Although we came from different disciplines and
backgrounds we always had interesting, intellectual interactions and that continue now also.
Immunity is the cornerstone of existence of all organisms including humans. In nature, every individual
organism or their community is surrounded by pathogenic and non-pathogenic organisms. We all interact,
defend and/or collaborate with a plethora of micro- or macro-organisms in our environment. It may be
alarming to note that despite our obsession to cleanliness and personal hygiene, every human individual
has more non-human DNA/cells than human DNA/cells. Thus, we are constantly exposed to non-self
environment; our health and disease conditions are dependent on continuing ‘conversations’, ranging from
simple interaction to active war. To participate in these ‘conversations’ all higher organisms including
humans have evolved various strategies of innate and adaptive immunities. The science of understanding
these crucial armaments and strategies is called ‘Immunology’.
Dr Ramesh has been teaching immunology to postgraduate students at the University of Mysore, for
more than two decades. His teachings always made significant impact on young minds, particularly in
this extremely interesting system of complex cellular and molecular network as well as protein-protein
interactions involved in molecular recognition discriminating self from non-self. He has put in lot of efforts
in simplifying and explaining various concepts, phenomena and strategies for easier comprehension. This
book showcases his teaching talent and highlights his passion to train the next generation and get them well-
educated in this interdisciplinary field.
The book covers (a) both fundamental and cutting-edge information in innate and adaptive immunity;
(b) all cellular and protein components and their complementary and collaborative interactions;
(c) their role and implications in autoimmunity, immunodeficiencies and hypersensitivity; and (d) their
applications as in monoclonal antibodies and tumor biology. The key features of the book include Learning
Objectives at the beginning of each chapter, ample illustrations for easy comprehension of the concepts and
mechanisms, boxes highlighting key facts and details, summary and, my favourite, several short answer
questions and essay type questions for students that cover various aspects described in the chapter. The
multiple choice questions at the end of the book, as the icing on the cake, will enhance and test their
understanding. Finally, there are two important appendices; one on transplantation and immune suppression,
and the other on immunoassays.
Overall, I believe this will be an excellent text book for undergraduate and postgraduate students and also
act as a reference book for students of medical and paramedical courses as well as for scientists entering the
field of immunology.
DR R MANJUNATHA KINI
Professor
Department of Biological Sciences
National University of Singapore
PREFACE
Immunology, the study of immune systems, originated when Edward Jenner demonstrated that the
incidence of smallpox can be prevented by introducing a small dose of fluid from cowpox pustule
into people. A greater push for immunology to develop into a distinct branch of biology came from
the work of Louis Pasteur who showed that not only smallpox, but also the incidence of variety of
diseases both in animals and humans can be prevented by immunization with vaccines. Since then,
immunization has saved mankind from sufferings and death emanating from epidemic and debilitating
diseases. Immunology is a field of biology and knowledge of this branch of study has grown leaps and
bounds due to development and advances in biochemical and molecular techniques. Incredible insights
into the nature and molecular mechanisms of interactions that occur between tissues and cells, within
the cells as well as between the cells and, molecules of the immune system have been the basis for rapid
advances of not only immunology but also medicine and pharmacology.
In the beginning of an immunology course, my students often used to express that immunology is
tough and complicated but as they become familiar with a reasonably good comprehension of the basic
concepts, they have always found that “Immunology is Amazing”. These interactions prompted me to
transform my lectures into a book. The content and language in this book has been kept simple for easy
comprehension of concepts, processes, mechanisms and applications that beginners always need. This
book will also be helpful for teachers who wish to become familiar with immunology for graduate or
post-graduate classes and also for venturing into higher levels of learning in immunology.
This book has been organized into two parts. The first part “Immunobiology” comprises 10 chapters
focusing on different components of the immune system. A clear comprehension of the content in
this part will create a mindset to understand and think further about the contents of second part,
“Immunology and Human Health”. The second part comprises 6 chapters that deal with importance
and relevance of the immune system in human health. The last chapter of second part is an overview
on immune system and cancer.
Every chapter begins with an introductory paragraph. Subsequently in addition to basic information,
advanced information distilled from recent review articles has been included with an intention to trigger
thinking in the young minds and to enable them to realize its research and application potential. There
are 78 box items altogether. In every chapter the box items provide clarity of a concept or additional
information in the same field or related field depending on the context. The content in this book has
been further supplemented with tables and figures for providing clarity. Additionally, two appendix
items are included to make the book more comprehensive.
The important pedagogical features are as follows:
● Case studies given in boxed items
● Illustrations: 240
xvi Preface
Publisher’s Note
McGraw Hill Education (India) invites suggestions and comments from you, all of which can be
sent to info.india@mheducation.com (kindly mention the title and author name in the subject line).
Piracy-related issues may also be reported.
PROLOGUE…
What is cowpox?
Cowpox is a viral skin disease in cows caused by cowpox virus. The affected cows develop blisters
on udders. The virus is transmitted from cows to humans when the udders are touched while milking
the cow. The symptoms of cowpox infection include appearance of red blisters on the hands of
infected person.
Jenner developed a theory that cowpox not only protected the people against smallpox but also could
be transmitted from one to another as a deliberate mechanism for protecting an individual from smallpox.
Jenner decided to try out the theory he had developed. Jenner met a young milkmaid Sarah Nelms, who
had fresh cowpox lesions on her hands and arms. He persuaded her and collected matter from cowpox
blisters and inoculated it into a young boy James Phipps on 14 May 1796; who subsequently developed
2 Immunology
Victims of smallpox: Left: Extent of suffering during the disease (Content provider: Centers for
Disease Control and Prevention), Right: disfigurement after recovery (Content provider: Centers for
Disease Control and Prevention/Dr. Robinson).
mild fever and discomfort in the axillae. Jenner repeated this process a number of days with a gradual
increase in the amount of matter he introduced into the boy. On 1 July 1796 Jenner inoculated the boy
again the matter and this time not with the matter from cowpox lesion but with the matter from a fresh
smallpox lesion. Phipps never caught smallpox and
Jenner concluded that protection was complete. Thus,
Jenner established a method to prevent the incidence
of disfiguring and often fatal disease smallpox and it
took him twenty years of observation, analysis, and
experimentation by the virtue of which, the current
practice of vaccination took its origin. Jenner decided
to call this new procedure as vaccination (Latin: vacca
= cow) in honour of the part played by Sarah and her
cow ‘Blossom’ in his research. In 1798, after adding
few more cases to his initial experiment, Jenner
published his work as a small booklet titled “An Inquiry
into the Causes and Effects of the Variolae Vaccinae,
a disease discovered in some of the western counties
of England, particularly Gloucestershire and Known Edward Jenner introducing fluid from a
by the Name of Cow Pox”. Jenner’s discovery was cowpox blister into the arm of James Phipps
so successful, that in 1840 the government that was (sblazak.wordpress.com)
Prologue… 3
ruling at that time banned any other treatment for smallpox other than the one described and established
by Jenner. Jenner’s method of preventing the incidence of smallpox spread quickly throughout Europe.
It was nearly 100 years, before the procedure of
vaccination was applied to other diseases also. The French
scientist Louis Pasteur was responsible for initiating such a
work by taking the lead from Edward Jenner. Louis Pasteur
was born in Dôle, France. At the age of 20, he received his
bachelor’s degree in science. At Écôle Normale, Paris he
worked on crystallography for his doctoral degree. When he
was 29 years old, he became the chairman of the department
of chemistry at the University of Strasbourg, Strasbourg,
France where he began studying fermentation. At the age
of 32, Pasteur became professor of chemistry and dean of
sciences at the new University of Lille. At this time, Lille
was the centre of alcohol manufacture in France. Soon after
his arrival at Lille, a producer of vinegar requested Pasteur
for help. The vinegar producer could not understand why his
vinegar made from beet juice sometimes spoiled and wanted
to know how to overcome this problem. Pasteur conducted
a microscopic examination of the beet juice and found that Louis Pasteur (1822–1895)
it contained alcohol and yeast. He suggested that the yeast (www.gardenofpraise.com)
was causing the beet juice to ferment. He also demonstrated
that killing of the yeast without spoiling the product is possible by controlled heating of the beet juice.
This process, called “pasteurization,” was widely employed to preserve a number of foods such as
cheese and milk. Pasteur’s discovery brought tremendous improvements in fermentation and heralded
a new era in the brewing and wine industries. Pasteur was an accomplished scientist. In 1857, he was
appointed Director of Scientific Studies at the Ecôle Normale in Paris.
The extraordinary contributions of Louis Pasteur were development of the germ theory of disease
and the use of vaccines to prevent the diseases. Experiments in his lab on vaccination as a deliberate
attempt to prevent the incidence of a disease began in 1881. At that time, chicken cholera (caused by
what we call today Pasteurella multocida) was a serious problem for farmers. The rapid spread of this
disease would have wiped out the entire flock in just three days. Pasteur had identified the cholera
bacillus and was growing it in pure culture. When injected with the culture, the chicken invariably died
in 48 hours. Unexpected discoveries by accident are not new to science. An incident that occurred in the
laboratory of Louis Pasteur led to the discovery of a vaccine for chicken cholera. Charles Chamberland,
who was working with Pasteur, forgot to inject the ‘disease’ into some chickens and went away on
holiday. When he came back, he saw the jar of bacteria placed on a side in the lab and realized that
he did not do the job that was told. He thought he would inject it into the chickens anyway and made
injections. He was amazed to observe that none of those chickens died; which usually would have
died in 48 hours. He reported his observations to Pasteur. Chamberland was asked to repeat what he
had done but with a fresh culture of chicken cholera germs. In the next set of experiments, they had
two groups; the first group consisted of the chickens that were already injected with old culture and
another group that were not (new batch of chickens). Chamberland injected fresh cultures into these
two groups of chickens. The result was again amazing; the chickens that were previously injected with
the old culture survived; while the other group of chickens that were previously never injected with old
cultures died. So to say, the chickens that were inoculated with the old culture had become resistant
4 Immunology
(immune) to chicken cholera. Pasteur was of the opinion that their bodies had used the weaker strain
of germ to form a defence against the more powerful germs in the fresher culture. When Pasteur saw
these results he realized that he was repeating the work of Jenner that was done 85 years earlier; which
had enabled Jenner to confer immunity to smallpox in humans by vaccinating individuals with a mild
form of cowpox. Pasteur then prepared nonvirulent (attenuated) cultures of chicken cholera vaccines by
growing the cholera bacillus at 42°– 43°C; at which temperature the bacillus is rendered non-infectious.
With this, they had also discovered that a weakened form of a disease can act as a vaccine.
Pasteur further thought, if attenuated cholera bacillus could render chickens resistant to the disease,
injection of an attenuated anthrax bacillus must render the sheep immune to anthrax. By various
techniques involving oxidation and aging, Pasteur found that anthrax vaccines indeed prevented anthrax
in laboratory trials. In April 1881, Pasteur announced that his team was successful in founding a way to
weaken anthrax germs and so could produce a vaccine against anthrax. Overwhelmed by the successes
with anthrax and fowl cholera diseases, Pasteur over the next 2–3 years got involved in identification
and isolation of microbes for many other diseases; including swine erysipelas, childbirth fever, and
pneumonia. The most famous success of Pasteur’s research was the development of a vaccine against
rabies. From the experimental observations, Pasteur conceived the idea and provided evidence that
pathogens could be attenuated or weakened or disabled from causing the disease by exposing them to
environmental insults such as high temperature, oxygen, and chemicals. Though Pasteur proved that
vaccination provided immunity, he did not explain how it worked; may be Pasteur’s priority was to
develop vaccines for a variety of diseases, not to look into the mechanisms of how it worked. At the
age of 46, Pasteur suffered a serious paralytic stroke. He died in 1895 after suffering additional strokes.
He was buried, a national hero, by the French Government. Thus, Edward Jenner laid the foundation
for immunology and Louis Pasteur was the first to initiate the development of the field of immunology,
which now has grown boundless to encompass a variety of disciplines that are related to human health
and welfare.
A group of scientists including Paul Ehrlich, Elie Metchnikoff, Jules Bordet, Emil von Behring led
by Louis Pasteur were responsible to presume the presence of a system in the body which was believed
to defend or protect the body from the invasion and attack of pathogens. They called it as immune
system; which literally means the system that exempts i.e. the system that exempts the body from
the disease. In other words, the immune system was thought to be responsible for providing absolute
protection against an injurious or a disease causing agent.
The immune system is usually compared to a fort and its various cells to soldiers. Now, we know
that it is a remarkable defense system that has evolved in vertebrates to protect them from invading
pathogenic microorganisms. The system is scattered all over the body from top to toe comprising
various organs, tissues, cells, and molecules. The system is capable of recognizing limitless variety of
foreign invaders and has evolved mechanisms to get rid of them. The efficiency of an immune system
lies in its ability to distinguish the “self” and “nonself” molecules. A variety of cells and molecules
precisely orchestrate the complex events that are associated with identification, neutralization and/or
destruction of the invader.
Immunity is the state of protection from infectious disease. It has both innate and adaptive
components. The innate immunity refers to the inherent potential of the system to impart resistance to
pathogens that invade an individual. This type of immunity is accomplished by anatomic, physiologic,
endocytic and phagocytic as well as inflammatory barriers to name a few. The adaptive immunity is an
acquired immunity. It is specific and reflects the presence of a functional immune system, capable of
specifically recognizing and selectively eliminating foreign bodies including microbes. Unlike innate
immunity, acquired immunity is characterized by specificity, diversity, self/nonself recognition, and
memory.
Prologue… 5
To accomplish the defensive tasks, the human blood contains a remarkable variety of cells each one
of them specialized to perform one or more functions during an immune response. They are dendritic
cells, monocytes, neutrophils, eosinophils, basophils, platelets, T cells (T-Lymphocytes), and B cells
(B-Lymphocytes). To enable their aggregation and orchestration of responses to a greater extent, a
number of organs and tissues are roped in by the evolutionary process. They include primary lymphoid
organs (bone marrow and thymus) and secondary lymphoid organs/tissues (adenoids, tonsils, spleen,
lymph nodes, Peyer’s patches, mucosal associated lymphoid tissue, and gut associated lymphoid tissue).
The blood vascular system and lymphatic system serve the function of transport of immunocompetent
cells from one organ to the other and to reinforce the dead cells from the regions where the new ones
are produced and matured. The amazing reality is that, all the immune cells including the red blood
corpuscles originate from a master cell, the blood forming (Hematopoetic) stem cell, residing in the
bone marrow.
The immune responses, whose ultimate outcome is to catch and dispose the unwanted microbe or
molecule, include the following:
(i) Innate immune responses that provide first line of defence. A variety of tissues, cells, and
molecules are involved in this response.
(ii) Cell mediated immune response which includes physical involvement of the cells (Phagocytosis
by Macrophages and Microphages, target cell killing by cytotoxic T cells, NK cells, and NKT
cells) that results in the removal of pathogens and antigens.
(iii) Humoral immune response which involves the production of antibodies by B cells resulting in the
formation of antigen-antibody complexes that are subsequently removed.
The recognition of antigens (nonself molecules) is accomplished due to antigen processing and its
presentation by antigen presenting cells, to the T cells. Further, involvement of various cell surface
molecules and receptors, for e.g. MHC (Major Histocompatibility Complex) Class I & II molecules,
TCRs (T Cell Receptors), CD (Cluster of Differentiation) molecules, and secretion of a variety of
cytokines by some blood cells play specific roles in the execution of immune responses that ultimately
leads to the neutralization or destruction of pathogens or nonself molecules.
Many kinds of cells such as NK cells, NKT cells, dendritic cells, and macrophages of innate
immune system as well as CD4+ Th1 cells and cytotoxic T cells play a key role in the fight against
malignant cells as long as the immune system is capable of distinguishing the self from nonself. When
the self/nonself recognition ability of the immune system goes astray, it leads to the development of
autoimmune diseases. Due to a variety of reasons when certain cells of the immune system are not
produced or do not mature or fail to respond to the invading pathogens, it results in the development of
immunodeficiency diseases. Such individuals become the victims of bizarre opportunistic infections
from which they die sooner or later.
Phenomenal advances in the field of biology and in particular immunology have enabled us to
understand the complexities and intricacies of cellular and molecular interactions prevailing in the
immune system. This knowledge in turn has paved the way for discoveries and development of
commercially viable therapies and drugs for human health care. The emergence of many new pathogens
and drug resistant varieties have become a major threat and challenge for human survival. Consequently,
the quest for the discovery of drugs and development of measures to counter the pathogens in order to
reduce mortality and suffering continues…!!!
PART-I
Immunobiology
LEARNING OBJECTIVES
After studying this chapter, the student will come to know
✓ What is immunity and different types of immunity
✓ The cells, molecules, and the mechanisms of innate immunity
✓ The types and mechanisms of adaptive immune response
✓ The interaction between innate and adaptive immunity and its importance
A variety of infectious microorganisms enter our body via the air we breathe, the water we drink, the
food we eat, the injuries that damage our skin or organs and yet, most of the times we remain resistant
to these infections since we have an immune system that provides protection. There are two ways by
which the immune system provides protection. They are innate or less specific immunity, which is the
first line of defense and the adaptive or specific immunity which is the second line of defense. These
two types of immunities operate by distinct mechanisms. At the same time, they also interact at different
levels to enhance the efficiency of the immune system. Immunity is defined as the state of protection of
an individual from an infectious agent or a foreign substance or a disease. In vertebrates, the immune
system has evolved remarkably to protect them from the pathogens or any kind of unwanted chemical
substances (antigens) before or after gaining entry. It consists of diverse organs and tissues that are
spread throughout the body. It is capable of generating enormous variety of cells and molecules. These
cells and molecules orchestrate or coordinate the complex process of identification, neutralization, or
destruction; as a consequence of which the microbe or foreign substance that comes in contact or that
has entered the body gets eliminated. Thus, the immune system can be compared to the military, its
various cells to soldiers, and the molecules to the weapons.
Usually antibodies are produced in an animal after it is exposed to an antigen (antigenic challenge).
The antibodies thus produced will neutralize the antigen by forming antigen-antibody complexes and
these complexes are later eliminated by different means. However, natural immunity may be present
in animals, which have not been immunized or infected with a pathogen, but still remain resistant. The
reason being, some antibodies are produced in individuals even in the absence of specific antigenic
10 Immunology
challenge. These antibodies are called normal antibodies or natural antibodies. They are found even
in germ-free animals fed on an antigen-free diet. Natural antibodies are immunoglobulin M (IgM)
isotype. They are normally present in the circulation of humans and other mammals that have never
been exposed earlier to those antigens to which they bind. These antibodies are in contrast to immune
antibodies, which are produced in response to an antigen. For example, isohemagglutinin (from
human plasma) is an antibody against the erythrocytes of other individuals. Natural antibodies are
present in horse against cholera, typhoid, and dysentery. Similarly, rabbits have natural antibodies
against pneumonia and dysentery. Natural antibodies against foreign erythrocytes are found in the
serum of various animal species. For example, swine has antibodies against erythrocytes of sheep, goat,
rabbit, and humans. Rabbit possess antibodies against the erythrocytes of guinea pig, horse, sheep, and
humans. While humans have in the serum, natural antibodies against rabbit, sheep, ox, horse, pigeon,
and guinea pig erythrocytes.
There are many direct factors such as nutritional status and age as well as indirect factors such as
personal hygiene, living conditions, and socioeconomic status that play a major role in host-parasite or
host-pathogen relationships and determine the ability of the host to resist the infection.
In general, higher the host is malnourished or undernourished, the greater will be its susceptibility to
the pathogens. This is especially evident in very young hosts. Experimental animals that are maintained
with low protein diet become susceptible to infections.
Generally very young or very old hosts are susceptible to infection. Babies are at a risk of infection
after the passive immunity (got from the mother) is depleted and before its own immune system becomes
functional. Infections of pathogenic strains of Escherichia coli and/or Pseudomonas aeruginosa that
cause diarrhea are frequent in infants under the age of 1 year. In very old individuals (above 65 years)
there will be a decline in the abilities of the immune system because the homeostatic functions of many
organs decrease and they are more susceptible to respiratory infections.
Stress also plays a significant role in the incidence of diseases. Experiments with rats and mice have
revealed that exertion, fatigue, dehydration, poor diet as well as drastic climatic changes and all sources
of physiological stress enhance the susceptibility of an individual to infectious diseases.
Further, the ability of an individual to defy an infection depends on certain indirect factors that vary
greatly from person to person and also from region to region. Generally, an individual becomes more
susceptible to infections if personal hygiene, socio-economic status, and living conditions are poor.
In higher vertebrates such as mammals, we can observe the prevalence of two types of immunity known
as innate immunity and adaptive immunity. The innate immunity or less specific immunity or natural
immunity or native immunity provides the first line of defense against pathogens or microorganisms
and/or foreign bodies that invade an individual by different means. These pathogens or microbes would
have to surpass one or more defense barriers such as anatomic, physiological, endocytic, phagocytic,
and inflammatory barriers in an individual. These barriers form an integral component of innate
immunity and they occur in an individual from the very early life and are effective against a variety of
pathogens or microorganisms and/or foreign bodies.
The adaptive immunity, also called acquired immunity is specific and represents the functional
immune system that is capable of specifically recognizing and selectively eliminating microorganisms
and/or foreign bodies. This type of immunity does not come into play unless a microorganism or a
foreign body enters an individual for the first time or subsequently. Adaptive immunity or acquired
11
In higher vertebrates such as mammals, a variety of effective defense mechanisms are present in an
individual from the very early stage of life. These mechanisms are capable of protecting the individual
from potentially harmful microorganisms and/or foreign bodies. Activation of such a defense mechanism
does not depend upon prior exposure of the body to any particular microorganism. The innate immune
mechanisms are effective against a wide range of potentially harmful infective agents.
The susceptibility of different species to pathogens differs. For example, human beings are not
affected by a large number of animal pathogens such as hog cholera, cattle plague, myxomatosis
etc. However, we remain susceptible to cholera, leprosy, syphilis, diphtheria etc. In some diseases,
it is difficult for a pathogen to infect the host; however once the pathogen gains entry, the disease
progression occurs rapidly due to the lack of resistance from the host. For example rabies, although
common to both man and dogs, it is not readily established since the virus does not easily penetrate
the healthy skin. However, once infected, the resistance mechanisms both in man and dog are unable
to overcome the disease. An interesting and exceptional feature of rabies is that the progression of the
disease can be prevented by administering vaccine after the bite of a rabid dog.
Rabies
Vaccination results in active immunization. The general rule is that vaccination has to be carried
out well before the infection occurs; so that the immune system of an individual will be able to
neutralize the pathogen or its products that causes the disease by producing antibodies against it.
An exception to this general rule is vaccination for rabies; where immunization can be initiated after
an individual is infected.
The susceptibility of different individuals of the same species to a particular pathogen also differs.
Variations in resistance to an infection between different strains of mice have been demonstrated. In
man, such differences among individuals to a certain extent are dependent upon the personal hygiene,
nutritional as well as socio-economic background. Sometimes genetic abnormalities are an advantage
to the individual in resisting infections. For example in humans, the genetic abnormality namely sickle
cell anemia is caused due to the presence of defective alleles (Hbs/Hbs) in homozygous condition.
Individuals with alleles for normal hemoglobin are susceptible to malaria. However, the heterozygous
individuals who carry one normal and one defective allele (HbA/Hbs), are resistant to infection by
Plasmodium falciparum and, hence, to malaria.
12 Immunology
by a variety of microorganisms. However, they do have some alternative defenses. For instance, the
damp surface (mucus) of the mucous membranes present in the respiratory tract and in the nose act as
a trapping mechanism and together with the action of cilia, sweep the foreign particulate material in
such a way that it passes into the throat, where it is swallowed. The acidic gastric juice in the stomach
destroys the microorganisms present in it. The microbes and foreign particles trapped within the mucus
are also removed by mechanical means such as coughing and sneezing.
Sneezing
When we inhale an irritant, it is sensed by the nerves
in the nostril. In response to which, the brain signals
the lungs to inhale deeply. The airways then close
to build air pressure in the lungs. This pressure
is suddenly released in a sneeze; thereby the
respiratory system gets rid of the irritant.
2. Physiologic barriers
The physiologic barriers that include temperature, pH, various soluble, and cell associated molecules
provide unfavorable conditions to many microorganisms. Many vertebrate species are resistant to
certain diseases basically because of their higher body temperatures (which of course is normal to that
species). For instance, chickens have higher body temperature (39.44°C/103 F) as compared to normal
human body temperature (37°C/98.6 F). Chickens are inherently resistant to anthrax because their
higher body temperature inhibits the growth of bacteria viz., Bacillus anthracis that causes anthrax.
The acidic nature of gastric secretion forms yet another barrier. Majority of the ingested microbes
are unable to survive in the stomach because of the acidic condition, the pH of which may vary from
2 to 4 depending on the type of meal. Many secreted body fluids contain bactericidal (an agent that
kills bacteria) components for example; Spermine and Zinc present in semen. The enzyme namely
lactoperoxidase present in the milk is a powerful oxidizing enzyme that can kill many kinds of bacteria.
Tears, urine, nasal secretions, cervical mucus, prostatic fluid and saliva contain a hydrolytic enzyme
namely lysozyme (muramidase). This enzyme cleaves the peptidoglycan layer of the bacterial cell
wall by hydrolyzing the bond between N-acetylglucosamine and N-acetylmuramic acid residues of
the peptidoglycan layer. A variety of bacteria are killed due to such damage caused to the cell wall.
A significant quantity of iron-binding protein lactoferrin (also called lactotransferrin) is present in
various secretory fluids such as milk, saliva, tears and nasal secretions. It is also released by activated
neutrophils and macrophages. Lactoferrin sequesters iron from the plasma; thereby reduces the
amount of free iron available to microbe and thereby limits the microbial proliferative ability. Mucous
membranes also produce enzyme lactoperoxidase that produces reactive oxygen form (superoxide)
which is toxic to many microorganisms. Further, animal tissues are found to contain a number of basic
proteins derived from damaged tissue and blood cells during the course of infection and inflammation.
This group includes basic proteins such as spermine and spermidine, which are capable of killing
tubercle bacilli and staphylococci.
14 Immunology
Rapid qualitative and quantitative changes occur in the host’s blood plasma during an acute infection.
These changes can bring down the virulence (ability to cause disease) of the pathogen. For instance, the
hosts are able to redistribute free iron in an attempt create a condition called ‘hypoferremia’. Conversely,
‘hyperferremia’ can cause infections by even the harmless organisms. When bacterial infection occurs,
macrophages are activated. As a consequence, many cytokines such as IL-1 (Interleukin-1), IL-6, IL-8
and TNF-a (Tumor Necrosis Factor-a) are released. These cytokines stimulate the liver to produce
many acute phase proteins. One such protein is C-reactive protein (CRP), the concentration of which in
plasma increases 1000 folds. CRP is a pentameric globular protein; which binds to phosphorylcholine
present on cell surface of many bacteria. Such an alteration of bacterial cell surface promotes
engulfment of bacteria by the phagocytes; and at the same time it can also activate the complement
proteins. Other acute phase proteins include mannose-binding lectin (MBL), surfactant proteins A (SP-A)
and D (SP-D). All these proteins act as opsonins since they promote phagocytosis by binding to the
bacterial cell surfaces on one side and on the other side, to the surface of phagocytes (Fig. 1.2). Further,
MBL activates alternative complement pathway. SP-A and SP-D are structurally related and are named
ACTIVATE
1
2
8 PHAGOCYTOSIS
7
Complement
fragments MACROPHAGES
IL-1, IL-6 3
Complement C-Reactive IL-8, TNF-a
activation Protein (CRP)
5
Mannose
binding lectin 4
Acute Phase
6 Proteins LIVER
Fig. 1.2
15
collectins (also known as defense collagens). They bind to cellular debris and dying cells and these
complexes later are engulfed by phagocytes.
Fever is caused due to the disturbances in hypothalamic thermoregulatory activity. There will
be an increase in the thermal “set point”. Adult humans have an oral temperature of 37°C or rectal
temperature of 37.5°C. Any increase in this set point results in fever. Several components of the
infecting organism such as (a) Bacterial endotoxins (b) N-acetylglucosamine-N-acetylmuramic acid
polymer of gram-negative bacteria (c) Derived portion of the peptidoglycan cell wall of both gram-
positive and gram-negative bacteria (d) Soluble enterotoxin of staphylococci (e) Erythrogenic toxin of
group A streptococci; will be able to trigger the fever. These components are called pyrogens or more
specifically, they are called exogenous pyrogens.
Certain microbes need free iron at a crucial concentration for the synthesis of their toxins and for
their proliferation; in the absence of which, their growth is retarded. Fever causes reduction of free
plasma iron. The fever also augments and mobilizes host’s macrophages, which in turn neutralize/
destroy pathogen by more than one mechanism. Certain cytokines such as IL-1, IL-6, TNF-a that are
produced by host macrophages act as endogenous pyrogens. IL-1 also causes proliferation, maturation
and activation of both T and B lymphocytes; which in turn augment the immune responses of the host.
Many microbes are unable to withstand higher body temperatures caused during fever and hence fail
to establish themselves in the host.
inactivates the initiation factor eIF-2 of the host cells which is needed for viral protein synthesis.
There are five major classes of interferons. Table 1.1 shows some interferons and secreting cells/
tissues. Interferon-a (IFN-a) which consists of a family of 20 different molecules, are secreted by
virus infected leucocytes. IFN-b is secreted by virus infected fibroblasts; whereas IFN-g is secreted by
antigen stimulated T cells. Placenta secretes two types of interferons viz., IFN-w and IFN-t.
Table 1.1
Interferon Secreting Cells/Tissue
IFN-a Leucocytes
IFN-b Virus infected fibroblasts
IFN-g Antigen stimulated T-cells
IFN-w Placenta
IFN-t Placenta
4. Microbial antagonism
Microbial antagonism is nothing but the property of microbes, in which a microorganism will be able
to kill or injure, or inhibit the growth of different microorganisms. The skin and mucous membranes
that are constantly in contact with organisms in the environment become readily colonized by various
microbial species. The microorganisms that are regularly found at any region in the body is referred
to as normal microflora. The growth and establishment of many potentially pathogenic bacteria and
fungi at these sites are suppressed by competition with normal microflora for essential nutrients or
due to the production of inhibitory substances namely bacteriocins by the normal microflora. Table
1.2 shows normal microflora of humans. Bacteriocins are toxic proteins secreted by Gram–negative
bacterial flora in our body. For example, E. coli synthesizes bacteriocins called colicins. These toxic
proteins inhibit the growth of similar or closely related bacterial strains. Other bacteriocins include
halocin, mutacin, nicin, sakacin, vibriocin etc. Thus, bacteriocins are made by nonpathogenic bacteria
that normally colonize the human body and are of interest in medicine. The Gram-positive bacterial
flora produces bacteriocin like peptides. The loss of these bacteria due to the use of antibiotics
may result in opportunistic infections by pathogenic microorganisms. For example, in humans, the
vaginal epithelium of adult female produces glycogen. The normal microflora of vaginal region viz.,
Table 1.2
Bacterium Skin Conjunctiva Nose Pharynx Mouth Lower Anterior Vagina
intestine urethra
Staphylococcus ++ + ++ ++ ++ + ++ ++
epidermidis
Staphylococcus + +/– + + + ++ +/– +
aureus
Lactobacillus sp. + ++ ++ ++
Escherichia coli +/– +/– +/– + ++ + +
Lactobacillus acidophilus produces lactic acid by fermenting this glycogen. As a consequence of the
activity of normal microflora, the pH of the vagina and cervix ranges from 4.4 to 4.6. This acidic
pH can prevent the invasion and colonization of this region by potential pathogens. These protective
commensals are disturbed when antibiotics are administered during any other illness. Under such
circumstances, the women become more susceptible to opportunistic infections by pathogens such as
Candida and Clostridium difficile. Further, it is also known that corynebacteria on the skin produce
fatty acids. These fatty acids inhibit the colonization of pathogenic bacteria.
Fig. 1.3
They are larger than neutrophils. Unlike the neutrophils, macrophages have single,
large nucleus. Hence they are also called mononuclear phagocytes (Fig. 1.3). They are distributed
throughout the body, which are both circulating in blood and fixed to tissues. These are the cells of the
reticuloendothelial system or RES.
The macromolecules that are present in the extracellular tissue fluid are engulfed by cells by
endocytosis, during which small regions of the plasma membrane invaginate or fold inward forming
endocytic vesicles. The diameter of the vesicles formed is approximately 0.1 mm. Endocytosis may
occur by one of the two methods: (i) Pinocytosis and (ii) Receptor mediated endocytosis (Fig. 1.4).
In pinocytosis, the macromolecules are phagocytosed by the way of nonspecific membrane
invagination. Whereas in case of receptor mediated endocytosis, the macromolecules are selectively
phagocytosed after they bind to specific membrane receptors. Such phagocytosed vesicles are called
endocytic vesicles. These endocytic vesicles fuse with each other and are delivered to endosomes. The
endosomes are acidic compartments present within the cells and they serve a sorting function. Their
acid environment causes dissociation of the receptor from its ligand. The receptor is recycled to the
plasma membrane of the cell, while the remaining macromolecules contained within the endosome
are passed along a different pathway to fuse with the primary lysosomes. The primary lysosomes
contain a large number of degradative enzymes such as acid phosphatase, acid RNase, acid DNase,
18 Immunology
Receptor
Plasma
membrane
Cytoplasm
Coated vesicle
Fig. 1.4
receptor mediated endocytosis (right)
b-glucuronidase, lipase, aryl sulfatase, cathepsins, peroxidase etc. The endosomes upon its fusion
with primary lysosomes become secondary lysosomes. Within the secondary lysosomes, the ingested
macromolecules are digested into small breakdown products (peptides, nucleotides, sugars) in the
endosomal processing pathway.
The ingestion of particulate material, including whole
pathogenic microorganism occurs by phagocytosis (Fig. Solid particle
1.5). Phagocytosis differs from endocytosis in many
Pseudopodia
respects. (a) In phagocytosis, the plasma membrane of the
phagocytic cell expands around particulate material to form
large vesicles called phagosomes. (b) The phagosomes are
10-20 times larger in size than endocytic vesicles. (c) The
expansion of plasma membrane in phagocytosis requires the
participation of cytoskeletal structure called microfilaments
(not in endocytosis). (d) Only specialized cells such as blood Plasma
membrane
monocytes, neutrophils and tissue macrophages are capable of
phagocytosis whereas virtually all cells carry out endocytosis.
The phagocytes have several mechanisms to deal with the
ingested microbe. Neutrophils can secrete transferin, which Phagosome
chelates the iron and prevents some bacteria from obtaining
this very important nutrient. While the macrophages are
Fig 1.5
capable of secreting Reactive Oxygen Intermediates (ROIs)
into the phagosomes and these ROIs are toxic to some
bacteria. Finally, the cytoplasmic granules and lysosomes fuse with phagosomes pouring the contents
of lysosomes into the phagosomes leading to digestion of the ingested material.
19
6. Inflammation
It is nonspecific and an important defense reaction.
Inflammation (Latin: inflammatio – to set on fire) is the body’s
reaction to the following:
(a) Invasion by an infectious agent
(b) Antigenic challenge or
(c) Even just a physical damage
As early as 1600 B.C., we find the description of classic
features of the inflammatory response in the Egyptian
writings. In the first century A.D., the Roman physician Celsus
described the “four cardinal signs of inflammation” as rubor
(redness), tumor (swelling), calor (heat) and dolor (pain). The
three major events that occur during inflammatory response
causing the cardinal signs include the following:
(i) Vasodilation (increase in the diameter of blood vessels)
of nearby capillaries; leading to an increased blood
supply to the infected area. Simultaneously, there will be
a vasoconstriction (decrease in the diameter of blood vessels) of the vessels that carry blood away
from the affected area. These two processes together cause the redness (rubor) and an increase in
tissue temperature (calor) of the affected area.
(ii) Increase in capillary permeability; caused by the retraction of the endothelial cells is another
major event. Such an increased permeability allows the escape of larger molecules (larger than
the molecules that normally escape) from the capillaries. As a result of this, antibody, complement
and other plasma enzyme systems reach the inflammatory site (site of infection/site of injury),
leading to the accumulation of fluid or exudates, causing swelling (tumor) and pain (dolor) of the
affected area.
(iii) Migration or Influx of leucocytes; wherein initially neutrophils and 5-6 hours later macrophages
and lymphocytes from the blood migrate out of capillaries into the surrounding tissues to carry
out their function.
The vascular endothelium serves as “gate keeper” that regulates the movement of blood borne
molecules and leukocytes in to the tissues. During inflammatory response, the cells from the blood
migrate into the tissues or the affected region. In this process, the adherence of leucocytes to the
endothelium of blood capillaries surrounding the affected tissues is the first step in the process of
migration of cells (Fig. 1.6). Such an adherence occurs due to the interaction of receptors viz., very
Rolling Margination
Extravasation
Endothalium
Fig. 1.6
tissues during inflammatory response
20 Immunology
late antigen-4 (VLA-4), P-selectin glycoprotein ligand-1 (PSGL-1) and leucocyte function associated
antigen-1 (LFA-1) that are present on the surface of leucocytes with the corresponding ligands viz.,
vascular cell adhesion molecule-1 (VCAM-1), P-selectin and intercellular adhesion molecule-1
(ICAM-1) on the activated endothelial cells respectively (Fig. 1.7). This process is called pavementing
or margination. After margination, the phagocytes insert pseudopodia between the endothelial cells
and dissolve the basement membrane of the blood capillary. They then emigrate between the capillary
endothelial cells into the tissue. This process is called diapedesis or extravasation. Once they are in the
tissues, the movement of leucocytes towards the site of infection is directed by chemicals (chemotaxis),
during which the phagocytes will actively migrate towards the source of chemotactic molecules or
chemotactic peptides. Tissue damage results in the generation of C3a and C5a complement fragments.
These fragments attract both neutrophils (microphage) and monocytes (macrophage). The moment
different phagocytes reach the site of infection/injury they begin to engulf bacteria (Fig. 1.7). Further,
the phagocytes also release lytic enzymes, which can damage surrounding healthy cells/tissue. The
accumulation of dead cells, digested material and fluid forms a substance called pus. The C3a and C5a
bind to local mast cells and cause the release of mediators (Histamine, Leukotrienes, Prostaglandins).
These mediators cause vasodilation, smooth muscle contraction and increased vascular permeability.
Similarly, endothelial damage induce plasma enzyme mediators (Bradykinin, fibrinopeptides) that also
bring about vasodilation and increased vascular permeability.
BLOOD TISSUES
Basement
membrane
Monocyte
Activation of
C3a complement
ca l
C5a la ssi
VLA-4 Mediators
o rc
VCAM-1
hw v e
Mast cell
s
ti
ay
Tissue
rna
Chemotaxis damage
Alte
Neutrophil
pat
Chemot Microbes
axis
C3a, C5a
IL-8 C5b67
Chemokines
PSGL-1 Endothelial
IL-1, IL-6, TNF-a damage
P-selectin
Prostaglandins
Lymphocyte Leukotrienes
Activated
macrophage
Extra vasation
LFA-1
ICAM-1
Fig. 1.7
acute inflammatory response
21
There are two types of inflammatory responses. They are (a) Acute inflammation which is rapid and
short lived, which may last for two weeks or more (b) Chronic inflammation is slow and long lived. The
former occurs due to infection or tissue damage or entry of an antigen; while the latter is caused due to
the persistence of infections as in mycobacterial infections that cause tuberculosis and leprosy. These
bacteria can resist phagocytosis and intracellular killing and thus can survive within macrophages. By
acute inflammatory response, the infection is eliminated. In case of chronic inflammatory response,
there will be an enhanced infiltration of lymphocytes and macrophages and the body attempts to wall off
and seclude the affected site by forming granuloma, as seen in case of bacterial infections (listeriosis,
brucellosis), fungal infections (histoplasmosis, coccidomycosis), helminth infection (schistosomiasis),
protozoan infection (leishmaniasis) and large antigen-antibody complexes (rheumatoid arthritis).
The adaptive immunity forms the second line of defense. It is the immunity, which is acquired and is
specific to a particular pathogen/antigen. The adaptive immunity may be of active, passive, or adoptive
type (Fig. 1.8).
Naturally acquired
(Natural infection)
ACTIVE
Artificially acquired
ADAPTIVE IMMUNITY
(Vaccination)
Naturally acquired
(Mother's antibodies)
PASSIVE
Artificially acquired
(Antibodies from other sources)
ADOPTIVE
Fig. 1.8
This form of immunity is acquired due to the exposure of an individual to a pathogen or an immunogenic
substance by natural or artificial means. Such an exposure results in the stimulation of immune system
to produce antibodies that are specifically directed against the inducing pathogen or immunogen.
Recognition of pathogen or immunogen by the immune system is followed by immunological memory;
that is, when the same individual encounters the same pathogen or immunogen subsequently, there will
be a rapid and heightened state of immune response again, ultimately resulting in the production of
specific antibodies to neutralize the pathogen or immunogen.
1. Naturally acquired
Natural stimulation of antibody producing mechanism occurs when we suffer and recover from a disease.
This will usually result in the long-term immunity and prevent incidence of the same disease again.
22 Immunology
2. Artificially acquired
The specific immunity could also be
acquired due to the stimulation of antibody
producing mechanisms artificially, by
deliberately introducing a pathogen or
some of their components or their products
which cause the disease (Fig. 1.9). For
artificial immunization, sublethal doses Fig. 1.9
of attenuated (weakened) organisms or
their products are employed. The pathogens can be attenuated or weakened by aging the cultures, or
by exposing the cultures to high temperatures or also by growing the pathogens in an unnatural host
(see Chapter 14). These procedures ensure a reduction or loss of virulence of the pathogens. Such
organisms that have lost virulence, but retain immunogenic property, are used for inducing specific
immunity. The preferred method of stimulating antibody response against many diseases is to use the
killed microorganisms. Many methods are employed to kill the microbes. Commonly, the microbes are
killed by treating the pathogens with acetone, formaldehyde, phenol, heat etc. Whenever toxins of the
pathogens have to be used for immunization, treatment of toxins with formaldehyde will convert most
of these to nontoxic antigenic toxoids that can be used for artificial immunization. These preparations
are called vaccines and the procedure of using them to induce immunity is called vaccination. The
immunity thus acquired is called Artificially acquired active specific immunity or artificially
acquired specific immunity. Some commonly used vaccines to induce resistance against diseases are
listed in Table 1.3.
Table 1.3
Vaccine Live Killed
Bacterial BCG (for tuberculosis) TAB (for enteric fever), cholera
Viral Oral poliomyelitis, measles, mumps Salk vaccine (for poliomyelitis), rabies
Bacterial products Toxoids: Diphtheria, Tetanus
Capsular polysaccharides: Meningococcus, Pneumococcus, Haemophilus
Surface antigen: Hepatitis B Virus
This type of immunity develops following the transfer of antibodies that have been made in another
individual. Such an immunity usually lasts only for a short period since these antibodies are catabolized
like any other normal globulin and thus disappear from circulation in the recipient after a short period.
23
1. Naturally acquired
During the first few months of an animal’s life or
human life, many diseases do not affect; which
otherwise ordinarily affect the animal or man in the
later part of life. This kind of resistance to many
diseases can be attributed to antibodies, which have
been transferred from the mother to the infant. Such
a transfer of antibodies to the growing embryo occurs
in the mother’s womb through the placenta and this
process is called transplacental passage. Passage of
antibodies through placenta has been demonstrated
in several animals. In both humans and animals such
as pig and cattle where placental and fetal circulatory Fig. 1.10
systems are separated by more than one layer of cells,
the passage of antibodies (mother’s IgA and IgG) also occur shortly after birth when the neonate feeds
on the first milk of the mother called colostrum (Fig. 1.10). The neonate continues to get the mother’s
antibodies in this way in the neonatal life. The antibodies that are obtained by the newborn through
colostrum are absorbed in the gastrointestinal tract of the newborn. These antibodies can neutralize
pathogenic microbes that attempt to colonize the infant’s gut. Further, IgG is taken up specifically from
the gut into the blood of the neonate and this transport is mediated by a receptor. The immunity thus
acquired by passive manner, is lost rapidly and then specific immunity will be acquired in an active
manner by individual’s own immunologic mechanisms during the course of life. Naturally acquired
passive immunity is quite important, since this mechanism protects the newborn during the period
when the immune capacities of the new born are yet to be developed.
2. Artificially acquired
This type of immunity includes the administration of antibody containing sera from the artificially
immunized animals (Fig. 1.11) or from the humans who have contracted and recovered from a disease.
Before the advent of antibiotics, immunization of an individual by this method was a common practice
in the treatment of diseases such as pneumonia.
Snake bite
Artificially immunized
animals
OR Antibodies Recipient
Naturally actively
immunized individuals
Fig. 1.11
24 Immunology
Antibodies that are raised in some other hosts are administered to prevent the severity of the disease.
Antibodies of human origin and animal origin are used for this purpose. The antibodies of human origin
(usually called immune serum globulin or gamma globulin) are preferred over those of animal origin
because of high incidence of adverse reaction to animal sera. In addition, the antibodies of human
origin provide protection for longer periods as compared to the antibodies of animal origin. The choice
for passive immunization is inevitable when the vaccines for active immunization are not available
or when the use of vaccines for active immunization is not advocated or if the recipient is primarily
immunodeficient whose immune system fails to respond to an antigen or in case of immunosuppressed
individuals.
When antibodies of animal origin are used, there will be a relatively high risk of developing serum
sickness. Hence, the use of human Ig is recommended wherever possible. During the preparations
of human Ig, the plasma which is positive for hepatitis B, hepatitis C or human immunodeficiency
virus (HIV) is discarded. If the use of antibodies of animal origin is inevitable, it has to be tested for
hypersensitivity before administering the same. Usually phenol is used as preservative for antibody
preparations. In some instances, thimerosal is also used.
Some reactions such as erythema and stiffness of local muscles occur commonly at the site of
injection. The discomforts caused by these reactions may persist for several hours. Occasionally mild
fever or malaise may occur. Rarely some side effects such as flushing, headache, chills and nausea also
occur. Further, anaphylactic reactions may occur rarely when repeated administration of the antibodies
is made. In 1998, the first monoclonal antibody named Palivizumab was licensed for its use, to prevent
an infectious disease namely respiratory syncytial virus in high-risk infants.
The artificially acquired passive immunity poses limitations because of the following reasons:
(a) The duration of immunity is short. It depends on the quantity of antibody injected and its life in
the circulation of the recipient.
(b) The antiserum has to be given very shortly after the exposure to the disease. It will not be helpful
if the antiserum is given after the disease has progressed/developed fully and damage has been
done.
(c) The antiserum has to be given in as large amounts as possible. However, when the antiserum
obtained from another animal/person is administered in large amounts, there is also a danger of
developing serum sickness by the recipient; which may result in severe side effects or even death.
However, in many instances the passive immunization is practiced (Table 1.4).
Table 1.4
Disease/condition Source of antibodies
Black widow spider bite Horse antivenin
Botulism Horse antitoxin
Diphtheria Horse antitoxin
Hepatitis A and B Pooled human immune gamma globulin
Measles Pooled human immune gamma globulin
Rabies Pooled human immune gamma globulin
Snake bite Horse antivenin
Tetanus Pooled human immune gamma globulin OR Horse antitoxin
25
A special type of immunity is acquired by the recipient due to the injection or introduction of
immunologically competent cells (Fig. 1.12). Instead of whole of the lymphocytes, an extract of
immunologically competent lymphocytes known as “transfer factor” can be used for this purpose.
This is being attempted in the therapy of some types of diseases such as lepromatous leprosy. Tissue
typing must be done for checking the compatibility before transferring immunologically competent
lymphocytes into the recipient to prevent incompatibility. Thus, it is a type of acquired immunity in
which immunity is transferred from one individual to another by the transfer of lymphocytes that are
immunologically active. Adoptive immunity is regarded as an intermediate between active and passive
immunity. It is active in the sense that it is based on the presence of actively functioning cells, which
have been stimulated by an antigen; now growing and functioning in a host after being transferred from
a donor. It is passive in the sense that the immunity is not produced in the host and is not the outcome
of its own active response to immunization.
Immunologically
competent
Donor
Lymphocytes
Recipient
Fig. 1.12
The innate immune system provides an immediate defense against infection. It is an additional system
for adaptive immune response. Virtually, there is a constant interaction between the cells and/or the
molecules concerned with the innate and adaptive immunity. It is possible that the innate immune
system plays an important role of reducing the quantum of pathogens during infection, thus reducing
the “burden” on adaptive immune response.
In the event of invasion by pathogens, the innate immune system is activated first to render initial
attack against the pathogens. Simultaneously, certain antigen presenting cells residing in different entry
points of pathogens are also activated. For instance, the skin in the adult humans has a surface area
of approximately 20 sq.ft.; infection could also occur through skin when it is damaged due to an
insect bite or an injury. The areas that are without skin (epithelial surfaces) measure about 4000 sq.ft.
Since most of these areas are exposed to the environment, the infection usually occurs due to the
26 Immunology
Table 1.5
PAMPs Source
Lipopolysaccharide, porins Gram-negative bacterial cell wall
Lipoproteins and lipopeptides Bacteria
Peptidoglycan, lipoteichoic acid Gram-positive bacterial cell wall
Lipoarabinomannan Acid-fast bacterial cell wall
Flagellin Bacterial flagella
Pilin Bacterial pili
Phosphorylcholine Microbial membranes
N-formylmethionine Bacterial proteins
DAMPs Source
Heat shock proteins Stressed, injured, infected, or transformed host cells
Altered membrane phospholipids Stressed, injured, infected, or transformed host cells
Different body cells have receptors called pattern-recognition receptors (PRRs) that recognize
PAMPs and DAMPs. Various body cells such as macrophages, endothelial cells, mucosal epithelial cells,
dendritic cells and lymphocytes typically have PRRs. Toll-like receptors (TLRs), the transmembrane
27
proteins present on the surface or on the endosomes of antigen presenting cells (such as dendritic cells)
were the first PRRs to be discovered and implicated in the innate immunity. The TLRs can recognize
a variety of components of bacteria and viruses that can be categorized into lipid, protein and nucleic
acid. These evolutionarily conserved PRRs are found to increase the antigenic response. They are also
found to form a link between the innate and the adaptive immunity. Altogether, the innate immune
system in humans is believed to recognize about 103 molecular patterns.
Following the entry of pathogen and/or an antigen several mechanisms, molecules and coordinated
sequence of events of innate and of adaptive immunity come into play (Table 1.6) almost simultaneously
to neutralize or eliminate the pathogen/antigen and to ensure the health of the individual.
Table 1.6
Feature Innate immunity Adaptive immunity
SUMMARY
✥
✥
28 Immunology
The spindle swings sidewise under the influence of the two cams which bear
against the upright stops
JOSEPH BRAMAH Sir SAMUEL Sir MARC I.
1748-1814 BENTHAM BRUNEL
Invented Lock, Hydraulic 1757-1831 1769-1849
press, 4-way cock, and 44 NEW MACHINES.
wood working machinery. BLOCK M’CHRY-1800-08
HENRY MAUDSLAY
1771-1831
Slide rest for metal work, Block machinery, Flour,
Sawmill and Mint mach’ry, Punches, Mill and Marine
Steam Engines, Fine screw cutting. Laid basis for
Lathe, Planer and Slotter
JOSEPH CLEMENT
1779-1844
Slide Lathe, Planer 1820 and 1824
Manufactured Taps and Dies Standard
Screw Threads
MATT. JAMES RICH’D. JOSEPH JAMES
MURRAY FOX ROBERTS WHITWORTH NASMYTH
1803-87 1808-90
Engines D- Index Versatile Std. Screw Index
Valve Cutting of Inventor, Threads Milling
Planer Gears Planer Foremost tool Shaper
Lathes, builder of the Steam
Planer 19th Century Hammer
Am. Machinist
With Abraham Darby, 3d, Wilkinson has the honor of having built,
in 1779, the first iron bridge, which spanned the Severn at Broseley.
This bridge had a span of 100 feet 6 inches, and a clear height of 48
feet, and is standing today as good as ever.[19] He invented also the
method of making continuous lead pipe.
[19] Smiles: “Industrial Biography,” p. 119. Boston, 1864. Also, Beiträge,
etc., 3. Band. S. 226.